RECRUITING

Virtual A2 Study for At Risk Children

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.

Official Title

Virtual Abecedarian Approach (A2) For IPNH-NDCP (Infants With Perinatal Neurological Histories - At Risk for Neurodevelopmental Disabilities or Cerebral Palsy)

Quick Facts

Study Start:2025-04
Study Completion:2030-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06643598

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 5 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. IPNH-NDCP patients, including:
  2. * Term-born children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy, or
  3. * premature children (born at less than 28 weeks gestational age).
  4. 2. Parent or legal guardian will also be enrolled as a participant
  5. 3. Parents must be English-speaking (able to provide consent and complete questionnaires).
  1. 1. Not suitable for study participation due to other reasons at the discretion of the investigator.
  2. 2. Infants with chromosomal abnormalities, genetic syndromes (for example, such as Down Syndrome or Trisomy18) and major congenital malformations will be excluded.
  3. 3. Infants with vision impairment will also be excluded from the study, as our study procedures do require intact vision to be able to complete.
  4. 4. For parents or legal guardians, there are no exclusion criteria.

Contacts and Locations

Study Contact

Melisa Carrasco McCaul, MD, PhD
CONTACT
608-577-2415
carrascomccaul@neurology.wisc.edu

Principal Investigator

Melisa Carrasco McCaul, MD, PhD
PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison

Study Locations (Sites)

University of Wisconsin Madison
Madison, Wisconsin, 53715
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Madison

  • Melisa Carrasco McCaul, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04
Study Completion Date2030-03

Study Record Updates

Study Start Date2025-04
Study Completion Date2030-03

Terms related to this study

Additional Relevant MeSH Terms

  • Hypoxic Ischaemic Encephalopathy (HIE)
  • Premature Birth
  • Cerebral Palsy
  • Neurological Disorder